Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04225559
Other study ID # XL018
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 1, 2019
Est. completion date December 31, 2021

Study information

Verified date December 2019
Source Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contact Fengyun Wang, Medical Doctor
Phone 86-010-62835610
Email wfy811@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To analyze the classification characteristics of gastrointestinal symptoms, the quality of life, the degree of anxiety and depression, and the satisfaction with the treatment of Chinese medicine in patients with FGIDs in Chinese Grade-A Tertiary Hospitals.

The characteristics of TCM(Traditional Chinese Medicine) syndromes and symptoms of the above-mentioned FGIDs will be analyzed, and the characteristics of TCM syndromes of FGIDs and their possible relationship with FGIDs subtypes will be analyzed.


Recruitment information / eligibility

Status Recruiting
Enrollment 4632
Est. completion date December 31, 2021
Est. primary completion date November 4, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

1. Symptoms has appeared for at least 3 months;

2. No organic disease and gastrointestinal alarm symptoms, which meet the diagnostic criteria of FGIDs;

3. Sign informed consent and be able to read and understand the questionnaire.

Exclusion Criteria:

1. A history of organic gastrointestinal diseases;

2. Alarm symptoms of digestive tract (such as melena, weight loss, fever, abdominal mass, ascites, anemia, family history of gastrointestinal tumors, etc.)

3. Have a history of mental diseases;

4. Unable to read and understand the questionnaire.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Xiyuan hospital Beijing Beijing
China Beijing Hospital of Traditional Chinese Medicine, Capital Medical University Dongcheng Beijing
China The Second Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou Guangdong
China Inner Mongolia Autonomous Region Hospital Chinese Medicne Hohhot Inner Mongolia
China Hong Kong Chinese Medicine Clinical Study Centre Hong Kong
China School of Chinese Medicine,Hong Kong Baptist University Hong Kong
China Liuzhou Traditional Chinese Medical Hospital Liuzhou Guangxi
China Jiangsu Provincial Hospital of Chinese Medicine Nanjing Jiangsu
China Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine Shanghai Shanghai
China The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang Liaoning
China Shanxi Provincial Hospital Of Traditional Chinese Medicine Taiyuan Shanxi
China First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin Tianjin
China Wuhan Hospital Of Traditional Chinese And Western Medicine(WUHAN No.1 HOSPITAL) Wuhan Hubei
China The Affiliated Hospital of Shaanxi, University of Chinese Medicine, Xianyang Shaanxi
China Guang'anmen Hospital,China Academy of Chinese Medical Science Xicheng Beijing
China The First Affiliated Hospital of Henan University of Chinese Medicine Zhengzhou Henan

Sponsors (1)

Lead Sponsor Collaborator
Xiyuan Hospital of China Academy of Chinese Medical Sciences

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rome IV functional gastrointestinal disease diagnosis questionnaire Fill in only at the time of the patient's consultation, to assess the patient's current situation.Investigation of patients with functional gastrointestinal symptoms according to Rome IV diagnostic criteria.Determine the type of disease based on the questionnaire. baseline
Secondary PHQ-15 Scale Fill in only at the time of the patient's consultation, to assess the patient's current situation.Score evaluation from of physical symptoms in patients with functional gastrointestinal disorders from 15 aspects. 0-4 points: very mild, 5-9 points: mild ,10-14 points: moderate,15-30 points: severe. baseline
Secondary SF-36 Scale Fill in only at the time of the patient's consultation, to assess the patient's current situation.Score evaluation from 8 aspects: physical function, role-physical, pain, global health status, vitality,social function,role-emotional, mental health.Use score changes to assess improvement in all areas of the patient. Maximum score is147.The higher the score, the better the status in all aspects. baseline
Secondary Hospital Anxiety and Depression Scale (HADS) Fill in only at the time of the patient's consultation, to assess the patient's current situation.Scoring to determine if a patient has symptoms of anxiety and depression:(0-7: asymptomatic, 8-10: suspicious symptoms, 11-21: there must be symptoms). baseline